Ledger.Open graph →
SEC Form D · filed October 6, 2020

Silverback Therapeutics, Inc

Offering
$85.0M
Sold
$85.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SEATTLE, WA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (16)

Jonathan L. Root · SEATTLE, WADirectorScott L. Platshon · SEATTLE, WADirectorRobert L. Hershberg · SEATTLE, WADirectorPeter A. Thompson · Seattle, WADirectorThilo L. Schroeder · SEATTLE, WADirectorLaura Shawver · San Diego, CAExec · DirectorVickie L. Capps · Brookfield, WIDirectorSaqib L. Islam · SEATTLE, WADirectorJonathan L. Root · SEATTLE, WADirectorThilo L. Schroeder · SEATTLE, WADirectorScott L. Platshon · SEATTLE, WADirectorLaura Shawver · Burlingame, CAExec · DirectorVickie L. Capps · Brookfield, WIDirectorRobert L. Hershberg · SEATTLE, WADirectorSaqib L. Islam · SEATTLE, WADirectorPeter A. Thompson · Vancouver, British Columbia, CanadaDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗